Home
NMTC
NMTC News

Latest NeuroOne Medical Technologies Corporation (NMTC) News on December 19, 2024

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

GlobeNewswire

2 days ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

GlobeNewswire

15 days ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

ACCESSWIRE

15 days ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

ACCESSWIRE

a month ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

GlobeNewswire

2 months ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

GlobeNewswire

2 months ago

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

GlobeNewswire

3 months ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

GlobeNewswire

3 months ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

3 months ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

4 months ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

GlobeNewswire

4 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

GlobeNewswire

4 months ago

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System

GlobeNewswire

6 months ago

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

GlobeNewswire

6 months ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

7 months ago

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

GlobeNewswire

7 months ago

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock

Simply Wall St.

7 months ago

Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

GlobeNewswire

8 months ago

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

GlobeNewswire

8 months ago

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

GlobeNewswire

8 months ago

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

GlobeNewswire

9 months ago

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

NeuroOne® to Participate in the 36th Annual Roth Conference

GlobeNewswire

9 months ago

NeuroOne® to Participate in the 36th Annual Roth Conference

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.

10 months ago

NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

10 months ago

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

GlobeNewswire

10 months ago

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

a year ago

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Business Wire

a year ago

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?

Simply Wall St.

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?

Issuer Direct Set to Exhibit and Sponsor the 2024 Vancouver Resource Investment Conference

ACCESSWIRE

a year ago

Issuer Direct Set to Exhibit and Sponsor the 2024 Vancouver Resource Investment Conference

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

GlobeNewswire

a year ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

GlobeNewswire

a year ago

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

New partnership aims to advance vaccine against MERS coronavirus

GlobeNewswire

a year ago

New partnership aims to advance vaccine against MERS coronavirus

The 3 Most Undervalued Penny Stocks to Buy in December

InvestorPlace

a year ago

The 3 Most Undervalued Penny Stocks to Buy in December

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

GlobeNewswire

a year ago

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

GlobeNewswire

a year ago

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

GlobeNewswire

a year ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

25 Highest Quality Furniture Brands in the World

Insider Monkey

a year ago

25 Highest Quality Furniture Brands in the World

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

GlobeNewswire

a year ago

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

CNW Group

a year ago

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

Manhattan Bridge Capital's (NASDAQ:LOAN) investors will be pleased with their 18% return over the last five years

Simply Wall St.

a year ago

Manhattan Bridge Capital's (NASDAQ:LOAN) investors will be pleased with their 18% return over the last five years

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

GlobeNewswire

a year ago

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2023 Earnings Call Transcript

Share on Social Networks: